Targeting Metallo-β-Lactamases: Discovery of Novel Dihydro-Chromeno Pyrrole (dCPs) Derivatives for Combating Drug-Resistant Infections
Journal of Medicinal Chemistry · 27.08.2026 · 69 (16) · 20015-20036
DOI: 10.1021/acs.jmedchem.6c01897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 04.08.2026. Verfasst von Pulkit Dhiman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry, CSIR-Institute of Microbial Technology, Chandigarh160036, India. Hauptthemen laut MEDLINE: beta-Lactamases, beta-Lactamase Inhibitors, Pyrroles, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: University Grants Commission, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India, CSIR - Institute of Microbial Technology.
Abstract (Originalsprache)
Clinically approved therapies have established that combining β-lactam antibiotics with β-lactamase inhibitors is an effective strategy to counter antibiotic resistance; however, infections caused by metallo-β-lactamase (MBL) producing bacteria remain a critical unmet medical need. Building on our previous efforts targeting clinically relevant MBLs, including New Delhi metallo-β-lactamase (NDM), Verona integron-encoded metallo-β-lactamase (VIM), and imipenemase (IMP), we report the design and synthesis of 40 novel dihydro-chromeno-pyrrole (dCP) derivatives using a scaffold-hopping approach. Several compounds displayed potent MBL inhibition and lead compounds 74 and 91 effectively restored the activity of mmeropenem and imipenem against carbapenem-resistant Gram-negative pathogens. Optimization efforts focused on improving ADME properties while maintaining potency, and lead compounds were further evaluated for their pharmacokinetic profiles. Docking studies revealed favorable binding interactions of inhibitors with MBL proteins, supporting and justifying the observed inhibitory activity. Overall, this study provides a robust framework for lead optimization and identifies promising candidates for preclinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Medicinal Chemistry, CSIR-Institute of Microbial Technology, Chandigarh160036, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad201 002, India.
- Structural Biology Lab, CSIR-Institute of Microbial Technology, Chandigarh160036, India.
- Solution Consultant-Biovia, Solize Partners India Pvt Ltd., Bangalore, Karnataka560092, India.
- National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Mohali, Punjab160062, India.
Förderung
- University Grants Commission
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
- CSIR - Institute of Microbial Technology
Zitieren
APA
Dhiman, P., Das, S., Narayanan, A. B., Kanhed, A. M., Thakur, K. G., & Chaudhari, V. D. (2026). Targeting Metallo-β-Lactamases: Discovery of Novel Dihydro-Chromeno Pyrrole (dCPs) Derivatives for Combating Drug-Resistant Infections. Journal of Medicinal Chemistry, 69(16), 20015-20036. https://doi.org/10.1021/acs.jmedchem.6c01897
Vancouver
Dhiman P, Das S, Narayanan AB, Kanhed AM, Thakur KG, Chaudhari VD. Targeting Metallo-β-Lactamases: Discovery of Novel Dihydro-Chromeno Pyrrole (dCPs) Derivatives for Combating Drug-Resistant Infections. Journal of Medicinal Chemistry. 2026;69(16):20015-20036. doi:10.1021/acs.jmedchem.6c01897
BibTeX
@article{Dhiman2026,
author = {Dhiman, Pulkit and Das, Satyajeet and Narayanan, Arya B and Kanhed, Ashish M and Thakur, Krishan G and Chaudhari, Vinod D},
title = {Targeting Metallo-β-Lactamases: Discovery of Novel Dihydro-Chromeno Pyrrole (dCPs) Derivatives for Combating Drug-Resistant Infections},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {16},
pages = {20015--20036},
doi = {10.1021/acs.jmedchem.6c01897}
}
EUVIMED